MedTrace Logo

Effects of Turkish Coffee and Green Tea in Fatty Liver Disease

NCT07768956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2026-08-17

No results posted yet for this study

Summary

Non-alcoholic fatty liver disease (NAFLD) is a common liver condition associated with metabolic disorders and lifestyle factors. This study aims to evaluate the effects of Turkish coffee and green tea consumption in addition to a Mediterranean diet intervention on liver fat content, biochemical parameters, and anthropometric measurements in individuals with fatty liver disease.

Participants received a 12-week Mediterranean diet program and were assigned to groups consuming Turkish coffee, green tea, or no additional beverage intervention. Changes in liver ultrasonography findings, liver enzymes, metabolic parameters, and body measurements were evaluated before and after the intervention.

Conditions

  • Non Alcoholic Fatty Liver Disease

Interventions

BEHAVIORAL

green tea

Participants consumed green tea three times daily as an adjunct to a Mediterranean diet intervention for 12 weeks.

BEHAVIORAL

Turkish Coffee

Participants consumed Turkish coffee twice daily as an adjunct to a Mediterranean diet intervention for 12 weeks.

BEHAVIORAL

mediterranean diet

participants received a Mediterranean diet intervention without additional Turkish coffee or green tea consumption for 12 weeks.

Sponsors & Collaborators

  • Okan University

    lead OTHER

Principal Investigators

  • Hande Öngün Yılmaz, PhD · BANDIRMA ONYEDI EYLUL UNIVERSITY, BANDIRMA VOCATIONAL SCHOOL

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-25
Primary Completion
2025-08-15
Completion
2025-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07768956 on ClinicalTrials.gov